Treatment Switching Outcomes in Patients With Macular Edema and a Poor Response to Therapy

This secondary analysis of the SCORE2 study examines the results of treatment switching in patients with central or hemiretinal vein occlusion who responded poorly to 6 months of aflibercept or bevacizumab therapy.

source https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2718837